Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders

被引：53
|
作者：
Ciron, J. [1 ,2 ]
Audoin, B. [3 ,4 ]
Bourre, B. [5 ]
Brassat, D. [1 ,6 ]
Durand-Dubief, F. [7 ]
Laplaud, D. [8 ]
Maillart, E. [9 ]
Papeix, C. [9 ]
Vukusic, S. [7 ,10 ,11 ]
Zephir, H. [12 ]
Marignier, R. [7 ,13 ]
Collongues, N. [14 ,15 ,16 ]
机构：
[1] Univ Hosp Toulouse, Hop Pierre Paul Riquet, Dept Neurol, Pole Neurosci, Pl Dr Baylac, F-31059 Toulouse 9, France
[2] Univ Hosp Poitiers, Dept Neurol, Pole Neurosci Locomoteur, 2 Rue Miletrie, F-86021 Poitiers, France
[3] Hop La Timone, AP HM, Pole Neurosci Clin, Dept Beurol, F-13005 Marseille, France
[4] Aix Marseille Univ, CRMBM, CNRS, UMR 7339, F-13005 Marseille, France
[5] Univ Hosp Rouen, Dept Neurol, F-76000 Rouen, France
[6] Univ Toulouse III, UMR 1043, F-31400 Toulouse, France
[7] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Dept Neurol Sclerose Plaques Pathol Myeline & Neu, F-69677 Lyon, France
[8] Univ Hosp Nantes, Dept Neurol, F-44093 Nantes, France
[9] Hop La Pitie Salpetriere, AP HP, Dept Neurol, F-75013 Paris, France
[10] CNRS, INSERM, Observ Francais Sclerose Plaques, Ctr Neurosci Lyon,U1028,UMR 5292, F-69003 Lyon, France
[11] Univ Lyon 1, F-69003 Lyon, France
[12] Univ Hosp Lille, Dept Neurol, F-59037 Lille, France
[13] CNRS, Ctr Rech Neurosci Lyon, FLUID Team, Fac Med Laennec,INSERM,U1028,UMR 5292, F-69008 Lyon, France
[14] Univ Hosp Strasbourg, Dept Neurol, F-67200 Strasbourg, France
[15] Univ Hosp Strasbourg, INSERM, Clin Invest Ctr, U1434, F-67200 Strasbourg, France
[16] Univ Hosp Strasbourg, INSERM, Biopathol Myelin, Neuroprotect & Therapeut Strategies,U1119, F-67200 Strasbourg, France
来源：
REVUE NEUROLOGIQUE | 2018年 / 174卷 / 04期
关键词：
Neuromyelitis optica; Rituximab; Guidelines; Recommendations; Treatment; ACTIVE RHEUMATOID-ARTHRITIS; LOW-DOSE RITUXIMAB; MEMORY B-CELLS; MULTIPLE-SCLEROSIS; ANTI-AQP4; ANTIBODY; DOUBLE-BLIND; FOLLOW-UP; PREGNANCY; EFFICACY; MULTICENTER;
D O I：
10.1016/j.neurol.2017.11.005
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
There is growing evidence of a preventive effect of Rituximab (RTX) in neuromyelitis optica spectrum disorders (NMO-SD). This monoclonal antibody against CD20 is becoming the most widely used preventive therapy in NMO-SD, as a first-line therapy or as a rescue therapy. Nevertheless, considerable heterogeneity still exists concerning the pre-treatment work-up, the vaccinations required before and under treatment, the number and dosage of infusions, prevention of the risk of infusion-related reactions, prevention of infections under treatment, and frequency of therapeutic cycles. Thanks to a collaborative work among NMO-SD experts belonging to the NOMADMUS project, we provide here recommendations for all these topics concerning RTX use in NMO-SD. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：255 / 264
页数：10
相关论文
共 50 条
  • [1] Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders
    McKeon, Andrew
    Pittock, Sean
    [J]. JAMA NEUROLOGY, 2013, 70 (09) : 1102 - 1104
  • [2] Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
    Jade, Jui Dilip
    Bansi, Srishti
    Singhal, Bhim
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2017, 20 (03) : 229 - 232
  • [3] Psoriasis induced by Rituximab in Neuromyelitis Optica Spectrum Disorders
    Cheng, S.
    Li, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP94 - NP94
  • [4] Neuromyelitis optica and neuromyelitis optica spectrum disorders
    Marignier, Romain
    Calvo, Alvaro Cobo
    Vukusic, Sandra
    [J]. CURRENT OPINION IN NEUROLOGY, 2017, 30 (03) : 208 - 215
  • [5] Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders
    Ip, Vincent H. L.
    Lau, Alexander Y. L.
    Au, Lisa W. C.
    Fan, Florence S. Y.
    Chan, Anne Y. Y.
    Mok, Vincent C. T.
    Wong, Ka-sing Lawrence
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 324 (1-2) : 38 - 39
  • [6] Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
    Marcinno, Andrea
    Marnetto, Fabiana
    Valentino, Paola
    Martire, Serena
    Balbo, Alessia
    Drago, Aurora
    Leto, Maria
    Capobianco, Marco
    Panzica, Giancarlo
    Bertolotto, Antonio
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2018, 5 (06):
  • [7] Low-dose Rituximab therapy for neuromyelitis optica spectrum disorders
    Novo, A.
    Correia, I.
    Marques, I.
    Batista, S.
    Sousa, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 542 - 542
  • [8] Spectrum of Neuromyelitis optica spectrum disorders
    Khan, F. M.
    Dave, D.
    Rao, P.
    Nirhale, S.
    Rohatgi, S.
    Naphade, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 685 - 685
  • [9] Neuromyelitis Optica Spectrum Disorders
    Eoin P. Flanagan
    Brian G. Weinshenker
    [J]. Current Neurology and Neuroscience Reports, 2014, 14
  • [10] Neuromyelitis Optica Spectrum Disorders
    Flanagan, Eoin P.
    Weinshenker, Brian G.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2014, 14 (09)
12345